YorLabs

YorLabs is a medical technology company that specializes in the development of advanced intracardiac echocardiography (ICE) systems. The company's primary innovation is a high-definition, real-time 3D ICE catheter designed to provide superior visualization during minimally invasive cardiac procedures. This technology is particularly valuable for electrophysiology and structural heart interventions, where precise imaging of the heart's internal structures is critical. Founded by a team of ultrasound industry veterans, YorLabs focused on improving procedural workflows and clinical outcomes through miniaturized, high-performance imaging hardware. In late 2023, the company was acquired by Abbott, integrating its ICE technology into Abbott's broader cardiovascular portfolio. The acquisition enhances Abbott's ability to offer comprehensive solutions for treating cardiac arrhythmias and structural heart defects.